Evidence map›Paper›PMID 42339055›Full record

ArticleEFSA journal. European Food Safety Authority2026

Statement on the findings presented in the Toxicological Profile for Mercury issued by the US ATSDR.

European Food Safety Authority (EFSA), Maria Bastaki, Chantra Eskes, Thorhallur Halldorsson, Irene Pilar Muñoz Guajardo, Katharina Vejdovszky, Barbara Viviani, Hans Steinkellner

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

European Food Safety Authority (EFSA)
Maria Bastaki
Chantra Eskes
Thorhallur Halldorsson
Irene Pilar Muñoz Guajardo
Katharina Vejdovszky
Barbara Viviani
Hans Steinkellner

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Food Safety Authority (EFSA) was requested by the European Commission to deliver a statement on the findings presented in the Toxicological Profile for Mercury issued by the US Agency for Toxic Substances and Disease Registry (ATSDR) in 2024. The statement was endorsed by the CONTAM Panel before approval by EFSA. Although some key methodological steps were not fully reported in the ATSDR document, it is unlikely that any major or relevant publications would have been missed. Based on the results presented by ATSDR (2024), including a new 28-day study in rats, there is no need for an update of the 2012 EFSA risk assessment for inorganic mercury, because EFSA considered this study not suitable to derive a reference point for dietary risk assessment. Consequently, the tolerable weekly intake (TWI) of 4 μg/kg body weight (bw), expressed as mercury, is still valid. For methylmercury, varying reporting approaches on the rationale for the methodological choices made during hazard characterisation appear to be the main driver of the differing guidance values. There is no clear indication that the minimal risk level (MRL) for methylmercury derived by ATSDR (0.1 μg Hg/kg bw/day, corresponding to 0.7 μg Hg/kg bw/week) is scientifically more robust than the TWI (1.3 μg/kg bw per week, expressed as mercury) established by EFSA in 2012. Consequently, the current EFSA TWI of 1.3 μg/kg bw per week, expressed as mercury, remains valid. Despite this, the advances in risk assessment methodology and the new evidence becoming available since the last EFSA assessment might merit an update of the 2012 Opinion.

Indexed as

ATSDR (Agency for Toxic Substances and Disease Registry)HBGV (health‐based guidance value)inorganic mercurymethylmercury

Identifiers

PMID42339055
PMCPMC13284742

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.